This expansion in New Jersey will create up to 100 jobs over the next few years is part of a global expansion strategy
Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Effective May 1st, 2020
Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.